July 6, 2020 / 1:21 PM / a month ago

BRIEF-Aim Immunotech Inc Signs Material Transfer And Research Agreement With Japan's National Institute Of Infectious Diseases And Shionogi

July 6 (Reuters) - AIM ImmunoTech Inc:

* AIM IMMUNOTECH INC - SIGNS MATERIAL TRANSFER AND RESEARCH AGREEMENT WITH JAPAN S NATIONAL INSTITUTE OF INFECTIOUS DISEASES AND SHIONOGI

* AIM IMMUNOTECH INC - AGREEMENT TO TEST AMPLIGEN AS POTENTIAL VACCINE ADJUVANT FOR COVID-19

* AIM IMMUNOTECH INC - UNDER AGREEMENT, AIM WILL PROVIDE AMPLIGEN SAMPLES FOR VARIOUS RESEARCH PROJECTS

* AIM IMMUNOTECH INC - DETAILS OF ALL PRECLINICAL AND CLINICAL RESULTS WILL REMAIN CONFIDENTIAL UNTIL RELEASED BY NIID AND SHIONOGI

* AIM IMMUNOTECH INC - THIS PROGRAM WILL BE A COLLABORATION BETWEEN NIID AND SHIONOGI, WITH AIM SUPPLYING AMPLIGEN Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below